This Fund Just Viridian: Key Takeaways for Investors
A major fund recently trimmed its stake in Viridian Therapeutics, signaling potential rotation rather than a verdict ...
Making the most of retirement involves embracing new experiences and opportunities. Uncover ways to enhance your retirement life.
19,615 articlesA major fund recently trimmed its stake in Viridian Therapeutics, signaling potential rotation rather than a verdict ...
Two CoinDCX co-founders were arrested by Indian police amid a fraud probe. The company denies wrongdoing and blames i...
Markets have cooled, but big tech still stands out. Here are five names that look unusually affordable, with clear pa...
Two concrete signals could shape the S&P 500 this week in the wake of Signet Jewelers' earnings. This guide explains ...
GOP-led statehouses are intensifying limits on abortion pills, while a new survey links telehealth-based pill use to ...
Jet fuel costs are climbing amid geopolitical tensions, prompting United Airlines to warn that airfares could rise as...
Qualcomm is navigating a tough start to 2026. A memory crunch, potential shifts with Apple, and a large buyback are m...
Citi trims its price target for Super Micro Computer to $25 from $39, citing governance and export-control concerns e...
Chewy just popped. stock momentum followed a better-than-expected 2026 outlook, even as Q4 growth stayed modest. This...
UBS cuts Mosaic’s price target to $27, citing squeezed phosphate margins from higher sulfur and input costs, as Wall ...
Geopolitics just accelerated volatility in energy markets. The rejection of a ceasefire proposal by iran has traders ...
Dogecoin slides toward the $0.09 mark as on-chain activity shows holders scooping up DOGE while institutional flows s...